StockData
Benitec Biopharma Inc. logo

Benitec Biopharma Inc. (BNTC) stock

BNTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$8.15−0.39 (-4.57%)

Close on Nov 17, 2026Market cap $284.29MP/E –Yield –

Benitec Biopharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Benitec Biopharma's price to book ratio was 1.8× on Nov 11, 2026, against 3.6× a year earlier. Over the last 5 years it ranged from 1.4× to 134.7×, with a median of 4.4×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.8×−1.9
2025Dec 31, 20253.8×−12.1
2024Dec 31, 202415.8×+14.2
2023Dec 29, 20231.7×−21.3
2022Dec 30, 202223.0×−82.9
2021Dec 31, 2021105.8×+73.0
2020Dec 31, 202032.9×+2.7
2019Dec 31, 201930.2×–

More Benitec Biopharma figures

See a number that looks wrong?